RE:RE:RE:RE:RE:RE:RE:RE:Volume pickup last 45 minsA possible NASH approval would come only in four to five years and it would cost a lot of money to get there and it will not drive the SP until some positive interim data. Oncology is a totally different ball game. If it works, the will be a flow of interim data and news, partnerships with proprietary drugs, new PDCs with generic drugs or radioisotopes, and a lot of different new clinical trials on different types of cancer, breakthrough therapy, accelerated approval, etc...
If oncology is really a breakthrough technology, I would not be surprised to see them drop NASH or to partner it if they can find a company willing to invest in it. We are not there yet. It will all depend on potential good results in oncology and how good these results could be.
CreatingApe wrote:
what do you think...With a marketing ace from PFIZER as our new CEO? Also do you think a life saving cancer treatment and life saving nash treatment will sell more easily than a niche drug for people who have HIV and want tighter stomachs?? Tired of the Thera cant sell drugs complaints. This is a whole other ball game now. New leader and targeting much more aggresive markets. If either drug gets approval we hit the lottery.